DK3146042T3 - Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop - Google Patents
Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitopInfo
- Publication number
- DK3146042T3 DK3146042T3 DK15724642.2T DK15724642T DK3146042T3 DK 3146042 T3 DK3146042 T3 DK 3146042T3 DK 15724642 T DK15724642 T DK 15724642T DK 3146042 T3 DK3146042 T3 DK 3146042T3
- Authority
- DK
- Denmark
- Prior art keywords
- csfv
- substitution
- protein
- fever virus
- swine fever
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24362—Methods of inactivation or attenuation by genetic engineering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
- G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14169703 | 2014-05-23 | ||
PCT/EP2015/061473 WO2015177369A1 (en) | 2014-05-23 | 2015-05-22 | Recombinant classical swine fever virus (csfv) comprising substitution in the tav epitope of the e2 protein |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3146042T3 true DK3146042T3 (da) | 2019-09-30 |
Family
ID=50774696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15724642.2T DK3146042T3 (da) | 2014-05-23 | 2015-05-22 | Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop |
Country Status (6)
Country | Link |
---|---|
US (1) | US9993544B2 (da) |
EP (1) | EP3146042B1 (da) |
CN (1) | CN106456741B (da) |
DK (1) | DK3146042T3 (da) |
ES (1) | ES2757927T3 (da) |
WO (1) | WO2015177369A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015177369A1 (en) | 2014-05-23 | 2015-11-26 | Boehringer Ingelheim Vetmedica Gmbh | Recombinant classical swine fever virus (csfv) comprising substitution in the tav epitope of the e2 protein |
CN106928327B (zh) * | 2017-04-01 | 2020-02-04 | 河南科技学院 | 猪瘟病毒配体表位多肽se242及其应用 |
CN108383895B (zh) * | 2018-05-03 | 2021-04-27 | 河南省农业科学院 | 一条可与猪瘟病毒e2蛋白结合的亲和肽及其应用 |
WO2020211801A1 (en) * | 2019-04-18 | 2020-10-22 | Boehringer Ingelheim Vetmedica (China) Co., Ltd. | Recombinant classical swine fever virus |
CN111718400B (zh) * | 2020-06-15 | 2021-11-02 | 苏州世诺生物技术有限公司 | 猪瘟病毒重组抗原及其制备方法和应用 |
CN115073608B (zh) * | 2022-03-22 | 2023-05-02 | 广东海大集团股份有限公司 | 一种猪瘟病毒e2的核酸-蛋白复合标记性疫苗 |
CN114835822B (zh) * | 2022-04-22 | 2022-11-04 | 浙江洪晟生物科技股份有限公司 | 猪瘟病毒的多聚体疫苗及其制备方法 |
CN117947057B (zh) * | 2024-03-26 | 2024-08-06 | 中国兽医药品监察所 | 一种用于预防猪瘟的mRNA纳米脂质体颗粒及其制备、检测方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10145969A1 (de) * | 2001-09-18 | 2003-04-10 | Maltagen Forschung Gmbh | Verfahren zum Herstellen eines Markerimpfstoffs gegen ein Säugervirus |
DE102004025452A1 (de) * | 2004-05-19 | 2006-01-19 | Boehringer Ingelheim Vetmedica Gmbh | Vakzine enthaltend BVDV |
US8846055B2 (en) * | 2006-05-30 | 2014-09-30 | The United States Of America, As Represented By The Secretary Of Agriculture | Virulence determinant within the E2 structural glycoprotein of classical swine fever virus |
AR062917A1 (es) * | 2006-09-22 | 2008-12-17 | Intervet Int Bv | Nuevo mutante de pestivirus para uso en una vacuna. |
EP2101815A4 (en) * | 2006-12-11 | 2010-10-06 | Boehringer Ingelheim Vetmed | EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS |
UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
EP2202298A1 (en) * | 2008-12-23 | 2010-06-30 | Stichting Dienst Landbouwkundig Onderzoek | Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
US20110150770A1 (en) * | 2009-12-18 | 2011-06-23 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine |
HUE029385T2 (en) * | 2010-05-18 | 2017-02-28 | Idt Biologika Gmbh | Marker vaccine for classical swine fever |
WO2015177369A1 (en) | 2014-05-23 | 2015-11-26 | Boehringer Ingelheim Vetmedica Gmbh | Recombinant classical swine fever virus (csfv) comprising substitution in the tav epitope of the e2 protein |
-
2015
- 2015-05-22 WO PCT/EP2015/061473 patent/WO2015177369A1/en active Application Filing
- 2015-05-22 US US15/312,249 patent/US9993544B2/en active Active
- 2015-05-22 CN CN201580026383.2A patent/CN106456741B/zh active Active
- 2015-05-22 DK DK15724642.2T patent/DK3146042T3/da active
- 2015-05-22 EP EP15724642.2A patent/EP3146042B1/en active Active
- 2015-05-22 ES ES15724642T patent/ES2757927T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
ES2757927T3 (es) | 2020-04-30 |
WO2015177369A1 (en) | 2015-11-26 |
EP3146042B1 (en) | 2019-07-10 |
US9993544B2 (en) | 2018-06-12 |
CN106456741A (zh) | 2017-02-22 |
CN106456741B (zh) | 2020-07-21 |
EP3146042A1 (en) | 2017-03-29 |
US20170119870A1 (en) | 2017-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL263801A (en) | Novel adeno-associated virus capsid proteins | |
DK3146042T3 (da) | Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop | |
DK3400293T4 (da) | Modificeret onkolytisk virus | |
DK3197472T3 (da) | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri | |
KR20180084817A (ko) | 항-siglec-9 항체 및 이의 이용 방법 | |
DK3180363T3 (da) | Sirp-alpha-immunoglobulin fusionsproteiner | |
DK3292141T3 (da) | Fusionsproteiner | |
BR112016030968A2 (pt) | análogos de pridopidina, preparação e uso destes | |
SG11201606624WA (en) | Antibody moleules to dengue virus and uses thereof | |
DK3508209T3 (da) | Sammensætninger med et svækket newcastle sygdoms-virus og fremgangsmåder til anvendelse til behandling af neoplasi | |
DK3107562T3 (da) | P97-ids-fusionsproteiner | |
DK3199179T3 (da) | Formulering af rekombinant fusionsprotein | |
DK3350334T3 (da) | Udtryk af rekombinante proteiner i trichoplusia ni pupper | |
DK3099791T3 (da) | Protein | |
BR112017009792A2 (pt) | anticorpos anti-pdgf-b e métodos de uso | |
DK3110837T3 (da) | Tatk-cdkl5-fusionsproteiner, sammensætninger, formule-ringer og anvendelse deraf | |
SG11201703366RA (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
DK3164410T3 (da) | Protein-indvinding | |
DK3044229T3 (da) | Peptider til anvendelse i behandlingen af oral mucositis | |
CL2015002110A1 (es) | Parvovirus porcino 5b, métodos de uso y vacuna | |
KR20180084995A (ko) | Fmdv 및 e2 융합 단백질 및 이의 용도 | |
DK3099793T3 (da) | Protein | |
DK3368068T3 (da) | Viruslignende partikler med effektiv epitopdisplay | |
DK3274447T3 (da) | Rekombinant fåresygevirus jeryl lynn 2 baseret vaccine | |
DK3271724T3 (da) | Anvendelse af en standard til påvisning af proteinaggregater i en proteinfejlfoldningssygdom |